NewGenIvf Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	4.58	5.43	5.14	5.94	4.12
Revenue Growth (YoY)	-19.43%	5.79%	-13.59%	44.34%	-
Cost of Revenue	3.6	3.61	3.45	4.41	3.09
Gross Profit	0.97	1.83	1.68	1.54	1.02
Selling, General & Admin	7.81	2.99	1.64	1.14	0.83
Operating Expenses	7.81	2.99	1.64	1.14	0.83
Operating Income	-6.84	-1.16	0.04	0.4	0.2
Interest Expense	-0.59	-0.78	-0.05	-0.08	-0.09
Interest & Investment Income	0.01	0.01	0	0	0
Other Non Operating Income (Expenses)	0.89	0.97	0.11	0.02	0.05
Pretax Income	16.9	-0.96	0.11	0.34	0.16
Income Tax Expense	-0.49	-0.49	-	0.21	0.29
Earnings From Continuing Operations	17.39	-0.47	0.11	0.14	-0.14
Minority Interest in Earnings	0.05	-0.05	0.02	0.32	0.14
Net Income	17.44	-0.52	0.13	0.46	-0
Net Income to Common	17.44	-0.52	0.13	0.46	-0
Net Income Growth	-	-	-71.61%	-	-
Free Cash Flow	-	-8.32	-1.84	1.62	1.42
Gross Margin	21.22%	33.62%	32.74%	25.87%	24.88%
Operating Margin	-149.54%	-21.36%	0.82%	6.71%	4.83%
Profit Margin	381.16%	-9.66%	2.54%	7.72%	-0.01%
Free Cash Flow Margin	-	-153.08%	-35.75%	27.19%	34.39%
EBITDA	-6.83	-1.14	0.07	0.5	0.37
EBITDA Margin	-149.21%	-21.00%	1.43%	8.40%	8.88%
D&A For EBITDA	0.01	0.02	0.03	0.1	0.17
EBIT	-6.84	-1.16	0.04	0.4	0.2
EBIT Margin	-149.54%	-21.36%	0.82%	6.71%	4.83%
Effective Tax Rate	-	-	-	60.51%	188.70%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q